Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201101810 Principal Investigator: Schroeder, Mark
Title: A Phase I Trial Evaluating the Effects of Plerixafor (AMD3100) and G-CSF in Combination with Azacitidine (Vidaza) for the Treatment of MDS
Phase: I Disease Site: Other Hematopoietic
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The overall purpose of this research is to evaluate the safety and tolerability of the combination of plerixafor, G-CSF, and azacitidine for the treatment of MDS.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)